GILD vs. BMY
Compare and contrast key facts about Gilead Sciences, Inc. (GILD) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GILD or BMY.
Correlation
The correlation between GILD and BMY is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GILD vs. BMY - Performance Comparison
Key characteristics
GILD:
2.34
BMY:
0.42
GILD:
3.37
BMY:
0.85
GILD:
1.42
BMY:
1.10
GILD:
1.92
BMY:
0.26
GILD:
12.82
BMY:
1.29
GILD:
4.44%
BMY:
9.71%
GILD:
24.37%
BMY:
30.08%
GILD:
-70.82%
BMY:
-70.62%
GILD:
-8.01%
BMY:
-24.21%
Fundamentals
GILD:
$133.70B
BMY:
$112.52B
GILD:
$0.38
BMY:
-$4.41
GILD:
0.22
BMY:
1.31
GILD:
$22.06B
BMY:
$36.44B
GILD:
$17.36B
BMY:
$23.27B
GILD:
$7.98B
BMY:
$11.69B
Returns By Period
In the year-to-date period, GILD achieves a 16.92% return, which is significantly higher than BMY's -0.08% return. Over the past 10 years, GILD has outperformed BMY with an annualized return of 4.37%, while BMY has yielded a comparatively lower 1.93% annualized return.
GILD
16.92%
-6.44%
28.75%
59.99%
10.94%
4.37%
BMY
-0.08%
-6.55%
4.74%
12.88%
3.65%
1.93%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GILD vs. BMY — Risk-Adjusted Performance Rank
GILD
BMY
GILD vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GILD vs. BMY - Dividend Comparison
GILD's dividend yield for the trailing twelve months is around 2.89%, less than BMY's 4.41% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.89% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.41% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% |
Drawdowns
GILD vs. BMY - Drawdown Comparison
The maximum GILD drawdown since its inception was -70.82%, roughly equal to the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for GILD and BMY. For additional features, visit the drawdowns tool.
Volatility
GILD vs. BMY - Volatility Comparison
The current volatility for Gilead Sciences, Inc. (GILD) is 7.17%, while Bristol-Myers Squibb Company (BMY) has a volatility of 8.96%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GILD vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities